Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levcromakalim Infusion Effect on Cranial Arteries
NCT03609008Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Jun 2018
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of levcromakalim (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoint: Change in circumference of cranial arteries (MMA, STA, and MCA). Started Jun 2018; status: completed.
02
Drugs
levcromakalim
Beyond the preview
Go deeper on NCT03609008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609008.